BioNTech
BNTX
BNTX
256 hedge funds and large institutions have $5.72B invested in BioNTech in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 84 increasing their positions, 82 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
256
Holders Change
-21
Holders Change %
-7.58%
% of All Funds
3.43%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
32
Increased
84
Reduced
82
Closed
50
Calls
$150M
Puts
$180M
Net Calls
-$30.6M
Net Calls Change
-$10.7M
Top Buyers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$374M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$93.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$93.2M |
| 4 |
Bank of New York Mellon
New York
|
+$43.7M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$35.8M |
Top Sellers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$80.1M |
| 2 |
Millennium Management
New York
|
-$49.6M |
| 3 |
BlackRock
New York
|
-$37.5M |
| 4 |
Temasek Holdings
Singapore
|
-$32.1M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$31.4M |
